Market research
IME.AU ImExHS Limited
AU AUD Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 17M
- P/E ratio
- Not available
- Analyst target
- 0.37
- Dividend yield
- Not available
- Beta
- 0.84
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- ISIN
- AU0000023053
- Market cap
- 17M
- P/E ratio
- Not available
- Analyst target
- 0.37
- Dividend yield
- Not available
- Beta
- 0.84
About
About ImExHS Limited
ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. The company operates in two segments: Software and Radiology. It offers medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; and ANTEROS, a cardiology software solution. It also provides radiological diagnostic services to hospitals and medical facilities; medical images and radiologists' interpretation; reports to develop artificial intelligence (AI) tools; and outsourced radiology services, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is based in Sydney, Australia.
Research context
ImExHS Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Diagnostics & Research
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the IME.AU discussion.
5 years, 6 months ago
ImExHS Limited is currently in a long term downtrend where the price is trading 0.8% below its 200 day moving average.
From a valuation standpoint, the stock is 98.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.2.
ImExHS Limited's total revenue rose by 24.5% to $6M since the same quarter in the previous year.
Its net income has increased by 67.3% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 86.6% to $-525K since the same quarter in the previous year.
Based on the above factors, ImExHS Limited gets an overall score of 4/5.